From Ars Technica
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
The risk appears small and data is mixed, but FDA wants patients to be aware.
TechBlastTechnology. Unpacked.UK & world technologyTechBlastTechnology. Unpacked.UK & world technologyFrom Ars Technica
The risk appears small and data is mixed, but FDA wants patients to be aware.